WCLC 2025 - Posters & ePosters-PT2.12.04 Osimertinib + Savolitinib in EGFRm Advanced NSCLC With MET Overexp And/Or Amp Post-Progression on Osimertinib: SAVANNAH PROs

PT2.12.04 Osimertinib + Savolitinib in EGFRm Advanced NSCLC With MET Overexp And/Or Amp Post-Progression on Osimertinib: SAVANNAH PROs

Asset Subtitle

Ike Igwegbe

Meta Tag

Speaker Ike Igwegbe

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy